160 related articles for article (PubMed ID: 8016092)
1. Combined intra- and extracellular immunization against human immunodeficiency virus type 1 infection with a human anti-gp120 antibody.
Chen SY; Khouri Y; Bagley J; Marasco WA
Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5932-6. PubMed ID: 8016092
[TBL] [Abstract][Full Text] [Related]
2. Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1.
Roben P; Moore JP; Thali M; Sodroski J; Barbas CF; Burton DR
J Virol; 1994 Aug; 68(8):4821-8. PubMed ID: 7518527
[TBL] [Abstract][Full Text] [Related]
3. A human recombinant Fab identifies a human immunodeficiency virus type 1-induced conformational change in cell surface-expressed CD4.
Bachelder RE; Bilancieri J; Lin W; Letvin NL
J Virol; 1995 Sep; 69(9):5734-42. PubMed ID: 7637018
[TBL] [Abstract][Full Text] [Related]
4. Intra- and extracellular immunization against HIV-1 infection with lymphocytes transduced with an AAV vector expressing a human anti-gp120 antibody.
Chen JD; Yang Q; Yang AG; Marasco WA; Chen SY
Hum Gene Ther; 1996 Aug; 7(13):1515-25. PubMed ID: 8864752
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of a novel neutralizing antibody targeting the CD4-binding site of HIV-1 gp120.
Qiao Y; Man L; Qiu Z; Yang L; Sun Y; He Y
Antiviral Res; 2016 Aug; 132():252-61. PubMed ID: 27387828
[TBL] [Abstract][Full Text] [Related]
6. Protection against HIV-1 infection in hu-PBL-SCID mice by passive immunization with a neutralizing human monoclonal antibody against the gp120 CD4-binding site.
Parren PW; Ditzel HJ; Gulizia RJ; Binley JM; Barbas CF; Burton DR; Mosier DE
AIDS; 1995 Jun; 9(6):F1-6. PubMed ID: 7662189
[TBL] [Abstract][Full Text] [Related]
7. Structure of the Fab fragment of F105, a broadly reactive anti-human immunodeficiency virus (HIV) antibody that recognizes the CD4 binding site of HIV type 1 gp120.
Wilkinson RA; Piscitelli C; Teintze M; Cavacini LA; Posner MR; Lawrence CM
J Virol; 2005 Oct; 79(20):13060-9. PubMed ID: 16189008
[TBL] [Abstract][Full Text] [Related]
8. Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1.
Labrijn AF; Poignard P; Raja A; Zwick MB; Delgado K; Franti M; Binley J; Vivona V; Grundner C; Huang CC; Venturi M; Petropoulos CJ; Wrin T; Dimitrov DS; Robinson J; Kwong PD; Wyatt RT; Sodroski J; Burton DR
J Virol; 2003 Oct; 77(19):10557-65. PubMed ID: 12970440
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro.
Barbas CF; Björling E; Chiodi F; Dunlop N; Cababa D; Jones TM; Zebedee SL; Persson MA; Nara PL; Norrby E
Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9339-43. PubMed ID: 1384050
[TBL] [Abstract][Full Text] [Related]
10. Natural human antibodies retrieved by phage display libraries from healthy donors: polyreactivity and recognition of human immunodeficiency virus type 1gp120 epitopes.
Llorente M; Sánchez-Palomino S; Mañes S; Lucas P; Kremer L; De Alborán IM; Torán JL; Alcamí J; Del Real G; Martínez-A C
Scand J Immunol; 1999 Sep; 50(3):270-9. PubMed ID: 10447936
[TBL] [Abstract][Full Text] [Related]
11. Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes.
Moulard M; Phogat SK; Shu Y; Labrijn AF; Xiao X; Binley JM; Zhang MY; Sidorov IA; Broder CC; Robinson J; Parren PW; Burton DR; Dimitrov DS
Proc Natl Acad Sci U S A; 2002 May; 99(10):6913-8. PubMed ID: 11997472
[TBL] [Abstract][Full Text] [Related]
12. Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody.
Burton DR; Pyati J; Koduri R; Sharp SJ; Thornton GB; Parren PW; Sawyer LS; Hendry RM; Dunlop N; Nara PL
Science; 1994 Nov; 266(5187):1024-7. PubMed ID: 7973652
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a mouse/human chimeric monoclonal antibody (C beta 1) to a principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.
Matsushita S; Maeda H; Kimachi K; Eda Y; Maeda Y; Murakami T; Tokiyoshi S; Takatsuki K
AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1107-15. PubMed ID: 1380258
[TBL] [Abstract][Full Text] [Related]
14. Cloning and biological characterization of human single-chain Fv fragments that mediate neutralization of HIV-1.
Srikantan V; Wang B; Satre MA; Ugen KE; Dang K; Scales F; Godillot AP; Williams WV; Weiner DB
AIDS; 1994 Nov; 8(11):1525-32. PubMed ID: 7848589
[TBL] [Abstract][Full Text] [Related]
15. Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody.
Marasco WA; Haseltine WA; Chen SY
Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7889-93. PubMed ID: 8356098
[TBL] [Abstract][Full Text] [Related]
16. Loss of serum antibodies to a conformational epitope of HIV-1/gp120 identified by a human monoclonal antibody is associated with disease progression.
Cavacini LA; Emes CL; Power J; Underdahl J; Goldstein R; Mayer K; Posner MR
J Acquir Immune Defic Syndr (1988); 1993 Oct; 6(10):1093-102. PubMed ID: 7692037
[TBL] [Abstract][Full Text] [Related]
17. Unique binding modes for the broad neutralizing activity of single-chain variable fragments (scFv) targeting CD4-induced epitopes.
Tanaka K; Kuwata T; Alam M; Kaplan G; Takahama S; Valdez KPR; Roitburd-Berman A; Gershoni JM; Matsushita S
Retrovirology; 2017 Sep; 14(1):44. PubMed ID: 28938888
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human monoclonal antibody IgG1b12 neutralizes diverse human immunodeficiency virus type 1 primary isolates.
Kessler JA; McKenna PM; Emini EA; Chan CP; Patel MD; Gupta SK; Mark GE; Barbas CF; Burton DR; Conley AJ
AIDS Res Hum Retroviruses; 1997 May; 13(7):575-82. PubMed ID: 9135875
[TBL] [Abstract][Full Text] [Related]
19. Structural mimicry of CD4 by a cross-reactive HIV-1 neutralizing antibody with CDR-H2 and H3 containing unique motifs.
Prabakaran P; Gan J; Wu YQ; Zhang MY; Dimitrov DS; Ji X
J Mol Biol; 2006 Mar; 357(1):82-99. PubMed ID: 16426633
[TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus type 1 neutralization by a single molecule of V3-targeted antibody.
Harada S
Microbiol Immunol; 2002; 46(12):857-62. PubMed ID: 12597360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
